课题基金 / 基金详情

Development of Iontophoresis Device for Plasmid DNA Transfection of Hypoxia Inducible Factor-1 to Improve Wound Healing

Development of Iontophoresis Device for Plasmid DNA Transfection of Hypoxia Inducible Factor-1 to Improve Wound Healing
开发用于缺氧诱导因子-1 的质粒 DNA 转染促进伤口愈合的离子电渗装置
批准号:
8829949
负责人:
John W Harmon
金额:
$14.98万
依托单位国家:
美国
项目类别:
财政年份:
2015
资助国家:
美国
项目状态:
已结题
起止时间:
2015-03-05 至 2016-09-04

项目摘要

项目成果

John W Harmon的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
DESCRIPTION (provided by applicant): Impaired wound healing is an unfortunate consequence of diabetes. It is also seen in the elderly, as well as individuals taking steroid medication. There is an urgent need for a therapy that will be safe, effective, and easy to apply to improve impaired wound healing. The situation is most urgent for individuals with diabetes, whose foot ulcers are the most frequent cause for lower extremity amputations in the United States. This project will lead initially to the marketing of a treatment modality that will promote healing of diabetic foot ulcers. It will be used for recalcitrant ulcers where healing is not progressing. It can be used for other difficult wounds as well. There is no effective treatment for such wounds at this time. Our goal for this SBIR is to develop a novel robust transfection strategy using iontophoresis. We have preliminary work showing that this can be effective. Iontophoresis is performed using a low voltage to create an electrical current in tissue. In our situation the negatively charged plasmid DNA is driven through the tissue from the anode to the cathode. For Phase 1 of this SBIR we will work with a group from Johns Hopkins University, School of Bioengineering, to optimize the electrode arrays and electrical parameters to achieve transfection suitable for improving wound healing. In Phase 2 we will assess the efficacy and safety of the approach in a porcine model. Our group has shown that the transcription factor Hypoxia Inducible Factor- 1 (HIF-1) can improve wound healing. DNA delivery of a peptide like HIF- 1 is necessary because simple application of peptide growth factors has not been effective because of poor absorption, and because the peptides are rapidly destroyed by peptidases in the dermis. The DNA plasmid delivery promotes continuous production of the peptide in the dermis to circumvent these delivery problems.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Development of Iontophoresis Device for Plasmid DNA Transfection of Hypoxia Inducible Factor-1 to Improve Wound Healing
  • 批准号:
    9243543
  • 项目类别:
  • 资助金额:
    $4.0万
  • 财政年份:
    2016
  • 负责人:
    John W Harmon
  • 依托单位:
Improve Wound Healing with HIF-CA5 DNA Vector and Electroporation
  • 批准号:
    7860120
  • 项目类别:
  • 资助金额:
    $17.31万
  • 财政年份:
    2010
  • 负责人:
    John W Harmon
  • 依托单位:
海外基金